Update shared on04 Sep 2025
Fair value Decreased 1.45%Despite a lower Future P/E and improved Net Profit Margin signaling better profitability and valuation, the consensus analyst price target for Medical Properties Trust edged down slightly from $4.93 to $4.86.
What's in the News
- Medical Properties Trust announced a lease agreement with NOR Healthcare Systems Corp. for six Prospect Medical Group California facilities, featuring a master lease with initial annualized rent of $45 million and CPI-based escalators beginning in 2026.
- All rent under the new lease will be deferred for six months, with 50% deferred for an additional six months; deferred rent will be repaid over the lease term.
- MPT has committed up to $60 million for seismic improvements over the next four years, increasing the lease base and future rent.
- The company filed a $500 million at-the-market follow-on equity offering of common stock.
Valuation Changes
Summary of Valuation Changes for Medical Properties Trust
- The Consensus Analyst Price Target remained effectively unchanged, moving only marginally from $4.93 to $4.86.
- The Future P/E for Medical Properties Trust has fallen from 33.15x to 30.36x.
- The Net Profit Margin for Medical Properties Trust has risen from 11.77% to 12.67%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.